NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE134839 Query DataSets for GSE134839
Status Public on Dec 19, 2020
Title Profiling non-small cell lung carcinoma cell line PC9 treated with erlotinib
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary The non-small cell lung carcinoma (NSCLC) PC9 cell line is an established preclinical model for tyrosine kinase inhibitors. To be able to better understand the differences in response between individual cells, we performed treatment of PC9 cells grown in cell culture with erlotinib followed by Drop-seq. We were able to clearly distinguish cells that were treated with the drug for five different time points from untreated cells, and we discovered different cell populations within the treated cells, likely reflecting heterogeneity of drug resistant cells. We were able to identify specific biomarkers, as preferentially expressed genes, for each cell population. The results of our study will address preexisting and acquired drug resistance that limits clinical usefulness of targeted strategies, particularly in NSCLC.
 
Overall design Examining drug resistant cell populations using single cell RNA-seq
 
Contributor(s) Benevolenskaya EV, Aissa AF, Islam AB
Citation(s) 33712615
NIH grant(s)
Grant ID Grant title Affiliation Name
R01 CA211095 Role of KDM5A in pRB-mediated differentiation BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Elizaveta V. Benevolenskaya
Submission date Jul 25, 2019
Last update date Mar 22, 2021
Contact name Elizaveta V Benevolenskaya
E-mail(s) [email protected]
Phone 312-413-8947
Organization name University of Illinois at Chicago
Department Biochemistry and Molecular Genetics
Street address 900 S. Ashland Ave.
City Chicago
State/province IL
ZIP/Postal code 60607
Country USA
 
Platforms (1)
GPL18573 Illumina NextSeq 500 (Homo sapiens)
Samples (6)
GSM3972657 Day 0 PC9 erlotinib
GSM3972658 Day 1 PC9 erlotinib
GSM3972659 Day 2 PC9 erlotinib
This SubSeries is part of SuperSeries:
GSE149383 Drug resistant changes at the level of single cells
Relations
BioProject PRJNA556612
SRA SRP216361

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE134839_RAW.tar 6.9 Mb (http)(custom) TAR (of TXT)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap